Your trusted guide to clinical trials

Find clinical trials relevant to you, near you. Powered by AI.

Please select a valid location from the dropdown
56,893 active trials
183,820 study centers
45,494 people enrolled
noise

TrialX — your clinical trial finder

A new, easy way to participate in clinical studies.

Man doing running exercise
father and son photo
father and son photo

You are in great company.

Institutes that trust us.

New & updated studies

Browse all studies

Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment

Examining the effects of PeptiSleep, a plant-based sleep aid, in healthy males and females with mild to moderate sleep impairment

18 - 65 years of age Both Phase N/A

Safety and Efficacy of Intravenous Cemiplimab Plus BNT116 Versus Cemiplimab Alone in Advanced Non-Small Cell Lung Cancer in Adult Participants With PD-L1 ≥ 50%

The study is researching an investigational drug, called BNT116, in combination with cemiplimab. BNT116 and cemiplimab will each be called a "study drug", and together be called "study drugs" in this form. The study is focused on patients who have advanced non-small cell lung cancer (NSCLC). The aims of the …

18 - 100 years of age Both Phase 2
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Natural History, Pathogenesis, and Outcome of Ocular Disorders

Background The National Eye Institute (NEI) wants to evaluate and provide standard treatment to people with eye diseases. Objective To examine and treat people with eye diseases and learn more about eye diseases and how they are inherited. Eligibility People with eye diseases who can give consent or have a …

1 - 100 years of age Both Phase N/A
J Jacob Steinmetz, Professor

Hypoxemia in the First 24 Hours After Trauma - an Observational Study

The goal of this observational study is to investigate the occurrence of hypoxemia (an abnormally low concentration of oxygen in the blood) in trauma patients within the first 24 hours of hospital admission following arrival to a trauma center. The main questions the study aims to answer are: Do trauma …

18 - 100 years of age Both Phase N/A
C Caroline Babinec

CD30 CAR for CD30+ NSGCT

This is a phase 2 research study that enrolls adult subjects with Nonseminomatous Germ Cell Tumors (NSGCT). The purpose of this study is to create a repository and explore the presence of modified T cells in the subject's plasma or tumors. This study collects biospecimens (such as tumor tissue, blood, …

18 - 100 years of age Both Phase 2
H Haojun Chen, PhD

Evaluatioon of 177Lu-TATE-EB-01(LNC1010)in SSTR2-positive Tumors

177Lu-LNC1010(177Lu-EB-TATE-01) is a radiotherapeutic drug indicated in subjects with unresectable, metastatic somatostatin receptor (SSTR) positive neuroendocrine tumors (NETs). In this study, we designed and developed a new radioligand, EB-TATE-01 (second generation long-acting EB-TATE formula), through combining EB and altering the linker to further improve the pharmacokinetics and pharmacodynamics, leading to …

18 - 70 years of age Both Phase 1

Your clinical trial journey

Find a study

Search or browse for a clinical trial near you.

Check Eligibility

Learn more about the trial and check to see if you are eligible to take part in it.

Participate

If you prequalify, connect with the study team and let your trial journey begin!

Accelerating clinical research powered by AI

Building patient connection for a better future

Family

Join us in our mission to help accelerate clinical research.

We are on a mission to make 1 billion actions made towards clinical research. ‘Actions’ are anything from searching for trials, sharing a trial, getting in touch with a study team — or something as simple as becoming a volunteer.

Become a volunteer today

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.